glp-1 receptor agonists effects on cardiovascular risk reduction and mortality outcomes with vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study | Diabetologia GLP-1 receptor agonists (GLP-1RAs): cardiovascular
Description
Theoretically, FSH modulates the expression of IRS2, thus affecting glycogen synthesis and glucose uptake via the PI3K/Akt pathway (45)
Transient elastography in the diagnosis of pediatric non-alcoholic fatty liver disease and its subtypes
50% Reduction in Recurrent AUD Semaglutide use was associated with a 50% reduction in the risk of recurrent AUD diagnoses
doi:10.1515/jpem-2013-0122 90
